Ads
related to: acute leukemia- Indication Information
Review Clinical Study Results.
Watch Informative Videos
- Long Term Data
Review Long Term Data
Access Information For Physicians.
- Treatment Safety Info
See Treatment Important Safety
Information For Physicians.
- Download Resources
For Healthcare Professionals
About Our Treatment Option.
- Indication Information
Search results
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 3 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
Earnings call: Syndax Pharmaceuticals outlines robust Q1 2024 performance
Investing.com· 2 days agoSyndax Pharmaceuticals , Inc. (NASDAQ: NASDAQ: SNDX ) has efficiently executed its corporate...
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoKura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript May 4, 2024 Kura Oncology, Inc....
Penn Medicine wants stroke, heart, and other acute patients transferred to its hospitals as quickly...
Philly.com· 5 days agoThe ambulance that rescued Betty Hayes after her March stroke at a Lansdale church took her to Grand...
Biomolecular atlas for bone marrow offers unprecedented window into blood production
Medical Xpress· 4 days agoResearchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have revealed a powerful new bone marrow atlas that will offer ...
Syndax Pharmaceuticals Inc (SNDX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 2 days agoA: Neil Gallagher, President and Head of R&D at Syndax, emphasized the importance of NCCN guidelines, noting that the initial approval for revumenib in KMT2A rearranged acute
Cwm LLC Purchases 1,358 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
ETF DAILY NEWS· 23 hours agoCwm LLC boosted its position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 415.3% during the fourth quarter, according to its most recent disclosure with the Securities and ...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Zurcher Kantonalbank Zurich...
ETF DAILY NEWS· 5 days agoZurcher Kantonalbank Zurich Cantonalbank raised its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 9.0% in the fourth quarter, according to its most recent 13F filing ...
Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of...
The Pilot News· 4 days agoDeerfield Management and the Deerfield Foundation announced today they will honor the 2023-2024 recipients of the American Society of Hematology (ASH) Peter Steelman Scholar Award at the second ...
Kura Oncology (NASDAQ:KURA) Rating Reiterated by Wedbush
ETF DAILY NEWS· 6 days agoKura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a note issued to investors on Friday, Benzinga reports. Wedbush’s price target would ...